Literature DB >> 20428770

Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes?

So-Young Lee1, Ilseon Hwang, Young-Soo Park, Jerad Gardner, Jae Y Ro.   

Abstract

Gastric carcinoma is the most common cancer and the second most common cause of cancer-related death in Korea. Many studies have been reported regarding prognostic factors. Among the category I prognostic factors of gastric carcinoma, lymph node metastasis (nodal status) is considered to be the strongest prognostic factor. According to the current UICC (the International Union Against Cancer)/AJCC (American Joint Committee on Cancer) staging system, nodal status is categorized based on the number of metastatic lymph nodes (pN0, no metastasis; pN1, 1-6 lymph nodes positive; pN2, 7-15 and pN3, >15). Some groups have recently proposed the metastatic lymph node ratio (the ratio between metastatic lymph nodes and total dissected lymph nodes; MLR) as an alternative prognostic factor to supplement the limitations of the conventional N staging system, particularly when a limited number of lymph nodes is obtained. In the present study, we aimed to evaluate which lymph node assessment method, metastatic lymph node number vs. ratio of metastasis, was better to predict survival in comparison with known prognostic factors in advanced gastric carcinoma in Korea. In addition, we tried to determine what level of MLR was a statistically significant factor to get a meaningful separation of survival. Based on our study, we demonstrate that the MLR was a simple and reproducible prognostic factor that supplemented the limitation of the conventional N staging system, and provided more accurate prognostic stratification in advanced gastric cancer. In addition to patients' age, tumor size, and chemotherapy, MLR was a strong prognostic factor in multivariate analysis, although the number of lymph node metastases, was not a strong factor. The MLR demonstrated further survival influence in pN2 stage. Moreover, with the relationship to pT stage, MLR showed better survival information than that of ordinary AJCC pN stage. We also propose that the optimal cut off values for the MLR should be classified into four groups as follows: MLR0, 0; MLR1, >0-0.3; MLR2, >0.3-0.6 and MLR3, >0.6.

Entities:  

Mesh:

Year:  2010        PMID: 20428770     DOI: 10.3892/ijo_00000632

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

1.  Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Authors:  Leyla Kilic; Cetin Ordu; Meltem Ekenel; Ibrahim Yildiz; Serkan Keskin; Fatma Sen; Zeynep Gural; Oktar Asoglu; Ahmet Kizir; Faruk Aykan
Journal:  Med Oncol       Date:  2013-07-23       Impact factor: 3.064

2.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

3.  Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer.

Authors:  Can A Karaca; Ahmet Coker
Journal:  Indian J Surg Oncol       Date:  2018-10-26

4.  Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?

Authors:  Paolo Aurello; Niccolò Petrucciani; Giuseppe R Nigri; Marco La Torre; Paolo Magistri; Simone Tierno; Francesco D'Angelo; Giovanni Ramacciato
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

5.  Prognostic significance of lymph node ratio in patients with Merkel cell carcinoma.

Authors:  Alexandra Fochtmann; Georg Haymerle; Rainer Kunstfeld; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

6.  Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.

Authors:  Pengfei Gu; Jingyu Deng; Zhe Sun; Zhenning Wang; Wei Wang; Han Liang; Huimian Xu; Zhiwei Zhou
Journal:  Surg Today       Date:  2020-08-04       Impact factor: 2.549

7.  N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.

Authors:  Nakul P Valsangkar; Devon M Bush; James S Michaelson; Cristina R Ferrone; Jennifer A Wargo; Keith D Lillemoe; Carlos Fernández-del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2012-12-11       Impact factor: 3.452

8.  Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer.

Authors:  Wafi Attaallah; Kivilcim Uprak; Omer Gunal; Cumhur Yegen
Journal:  Indian J Surg Oncol       Date:  2016-01-09

9.  Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.

Authors:  Awais Ashfaq; Barbara A Pockaj; Richard J Gray; Thorvardur R Halfdanarson; Nabil Wasif
Journal:  J Gastrointest Surg       Date:  2014-06-11       Impact factor: 3.452

10.  Prognosis of patients with gastric cancer and solitary lymph node metastasis.

Authors:  Chun-Qiu Chen; Xiao-Jiang Wu; Zhen Yu; Zhao-De Bu; Ke-Qiang Zuo; Zi-Yu Li; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.